These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Antiarrhythmic and electrophysiologic actions of bethanidine sulfate in primary ventricular fibrillation or life-threatening ventricular tachycardia. Benditt DG; Benson DW; Dunnigan A; Kriett JM; Pritzker MR; Bacaner MB Am J Cardiol; 1984 May; 53(9):1268-74. PubMed ID: 6711426 [TBL] [Abstract][Full Text] [Related]
3. Bethanidine sulfate: efficacy in prevention of ventricular tachyarrhythmias during programmed stimulation. Report of a multicenter study of 56 patients. Teichman SL; Waspe LE; Matos JA; Kim SG; Fisher JD J Am Coll Cardiol; 1985 Sep; 6(3):510-7. PubMed ID: 3897340 [TBL] [Abstract][Full Text] [Related]
4. Bethanidine sulfate in paroxysmal ventricular tachycardia: toxicity and antifibrillatory actions. Bauman JL; Gallastegui J; Prechel D; Anderson JL Pharmacotherapy; 1986; 6(4):184-92. PubMed ID: 3774563 [TBL] [Abstract][Full Text] [Related]
5. Acute electrophysiologic effects of bethanidine sulfate in patients with ventricular tachycardia or fibrillation. DiMarco JP; Sellers TD; Shipe JR; Savory J; Spyker DH Am Heart J; 1984 Nov; 108(5):1244-9. PubMed ID: 6496282 [TBL] [Abstract][Full Text] [Related]
6. The efficacy of cibenzoline and propafenone against inducible sustained and nonsustained ventricular tachycardias in conscious dogs with isolated chronic right ventricular infarction: a comparative study with procainamide. Karagueuzian HS; Sugi K; Ohta M; Meesmann M; Ino T; Peter T; Mandel WJ Am Heart J; 1986 Dec; 112(6):1173-83. PubMed ID: 3788764 [TBL] [Abstract][Full Text] [Related]
7. Antiarrhythmic, antifibrillatory, and hemodynamic actions of bethanidine sulfate: an orally effective analog of bretylium for suppression of ventricular tachyarrhythmias. Bacaner MB; Benditt DG Am J Cardiol; 1982 Oct; 50(4):728-34. PubMed ID: 6812406 [TBL] [Abstract][Full Text] [Related]
8. Development of ventricular tachyarrhythmias in the conscious canine during the recovery phase of experimental ischemic injury: effect of bethanidine administration. Patterson E; Amalfitano DJ; Lucchesi BR J Cardiovasc Pharmacol; 1984; 6(3):470-5. PubMed ID: 6202974 [TBL] [Abstract][Full Text] [Related]
9. Electrophysiologic evaluation of the antiarrhythmic effects of N-acetylprocainamide for ventricular tachycardia secondary to coronary artery disease. Wynn J; Miura DS; Torres V; Flowers D; Keefe D; Williams S; Somberg JC Am J Cardiol; 1985 Nov; 56(13):877-81. PubMed ID: 2414983 [TBL] [Abstract][Full Text] [Related]
10. Meobentine sulfate: antiarrhythmic and electrophysiologic effects assessed by programmed electrical stimulation and ambulatory monitoring in patients with complex ventricular tachyarrhythmia. Report of a multicenter evaluation. Anderson JL; Reid PR; Platia EV; Akhtar M; Ruskin JN; Schaal SF; Jueng P; Long RA; Wenger TL Am Heart J; 1985 Oct; 110(4):774-84. PubMed ID: 3901715 [TBL] [Abstract][Full Text] [Related]
11. Comparison of noninvasive arrhythmia induction techniques with electrophysiologic studies and evaluation of lorcainide in patients with symptomatic ventricular tachycardia. Somberg JC; Butler B; Flowers D; Tepper D; Maguire W; Willens H; Keren G; Miura D Am J Cardiol; 1984 Aug; 54(4):49B-54B. PubMed ID: 6465047 [TBL] [Abstract][Full Text] [Related]
12. Effects of procainamide and lidocaine on electrically inducible ventricular tachycardia studied with programmed ventricular stimulation in post myocardial infarction. Iesaka Y; Aonuma K; Nitta J; Tokunaga T; Fujiwara H; Hiraoka M Jpn Circ J; 1988 Mar; 52(3):262-71. PubMed ID: 3373718 [TBL] [Abstract][Full Text] [Related]
13. Recurrent sustained ventricular tachycardia 3. Role of the electrophysiologic study in selection of antiarrhythmic regimens. Horowitz LN; Josephson ME; Farshidi A; Spielman SR; Michelson EL; Greenspan AM Circulation; 1978 Dec; 58(6):986-97. PubMed ID: 709782 [TBL] [Abstract][Full Text] [Related]
14. A dual electrophysiologic test for atrial antireentry and ventricular antifibrillatory studies. Effects of bethanidine, procainamide, and WY-48986. Wu KM; Hunter TL; Proakis AG J Pharmacol Methods; 1990 Apr; 23(2):87-95. PubMed ID: 2332983 [TBL] [Abstract][Full Text] [Related]
15. Procainamide induced sustained monomorphic ventricular tachycardia in a patient with benign premature ventricular complexes. Bhandari AK; Au PK; Rahimtoola SH Can J Cardiol; 1986; 2(1):6-9. PubMed ID: 2420424 [TBL] [Abstract][Full Text] [Related]
16. Effects of sotalol on ventricular tachycardia and fibrillation produced by programmed electrical stimulation: comparison with other antiarrhythmic agents. Nademanee K; Singh BN Am J Cardiol; 1990 Jan; 65(2):53A-57A; discussion 65A-66A. PubMed ID: 2403735 [TBL] [Abstract][Full Text] [Related]
17. Usefulness of the electrophysiology laboratory for evaluation of proarrhythmic drug response in coronary artery disease. Buxton AE; Rosenthal ME; Marchlinski FE; Miller JM; Flores B; Josephson ME Am J Cardiol; 1991 Apr; 67(9):835-42. PubMed ID: 1707220 [TBL] [Abstract][Full Text] [Related]
18. Antiarrhythmic drug efficacy at electrophysiology testing: predictive effectiveness of procainamide and flecainide. Wynn J; Torres V; Flowers D; Mizruchi M; Keefe D; Miura D; Somberg J Am Heart J; 1986 Apr; 111(4):632-8. PubMed ID: 3953384 [TBL] [Abstract][Full Text] [Related]
19. Lorcainide therapy for the high-risk patient post myocardial infarction. Somberg JC; Butler B; Torres V; Flowers D; Tepper D; Keefe D; Miura DS Am J Cardiol; 1984 Aug; 54(4):37B-42B. PubMed ID: 6465045 [TBL] [Abstract][Full Text] [Related]